Social defeat stress increases expression of μ-opioid receptor mRNA in rat ventral tegmental area

NeuroReport

Volumn 10, Issue 14, 1999, Pages 3015-3019

  Nikulina, Ella M ^a   Hammer Jr , Ronald P ^a,b   Miczek, Klaus A ^a,b   Kream, Richard M ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

In situ hybridization histochemistry; Neural plasticity; Social defeat stress; Substantia nigra; Ventral tegmental area; Opioid receptor; Opioid receptor encoding mRNA

Indexed keywords

MESSENGER RNA; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN SITU HYBRIDIZATION; MALE; MENTAL STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

EID: 0033615259     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199909290-00026     Document Type: Article

References (24)

1. Koob GF. Mol Psychiatry 1, 186-189 (1996).
2. Thierry A, Tassin J, Blanc G, and Glowinski G. Nature, 263, 242-243 (1976).
3. Imperato A, Angelucci L, Casolini P et al. Brain Res, 577, 194-199 (1992).
4. Tidey JW and Miczek KA. Brain Res 721, 140-149 (1996).
5. Miller JD, Speciale SG, McMillen BA and German DC. Eur J Pharmacol 98, 437-439 (1984).
6. Altier N and Stewart J. Brain Res 718, 203-206, (1996).
7. Mattews RT and German DC. Neuroscience 11, 671-625 (1984).
8. Johnson SW and North RA. J Neurosci 12, 483-488 (1992).
9. Kalivas P and Stewart J. Brain Res Rev 16, 233-244 (1991).
10. Miczek KA, Thompson ML and Tornatzky W. Subordinate animals: behavioral and physiological adaptations and opioid tolerance In: Brown MR, Koob GF and Rivier C, eds. Stress: Neurobiology and Neuroendocrinology. Marcel Dekker, New York, 1991: 322-357.
11. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press, 1986.
12. Hammer RP Jr and Cooke ES. Neuroreport 7, 2041-2045 (1996).
13. Klitenick MA, DeWitte P and Kalivas PW. J Neurosci 12, 2623-2632 (1992).
14. Noel MB and Gratton A. Synapse 21, 110-122 (1995).
15. Bontempi B and Sharp FR. J Neurosci 17, 8596-8612 (1997).
16. Min BH, Augustin LB, Felsheim RF et al. Proc Natl Acad Sci USA 91, 9081-9085.
17. Morgan JI and Curran T. Annu Rev Neurosci 34, 421-451 (1991).
18. Chnelweiss H, Glowinski J and Premont J. J Neurosci 8, 3376-3382 (1988).
19. Pinch EM, Heinrichs SC, Rivier C et al. Psychoneuroendocrinology 18, 495-507 (1993).
20. Miczek KA, Nikulina EM, Kream RM et al. Psychopharmacology 141, 225-234 (1999).
21. Harfstrand A, Fuxe K, Cintra A et al. Proc Natl Acad Sci USA 83, 9779-9783 (1986).
22. Marinelli M, Aouizerate B, Barrot M et al. Proc Natl Acad Sci USA 95, 7742-7747 (1998).
23. Zeman P, Alexandrova M and Kvetnansky R. Endocrinol Exp 22, 59-66 (1988).
24. Nikulina EM, Marchand JE, Miczek KA and Kream RM. Soc Neurosci Abstr 23, 126 (1997).